Neuromuscular Disease

Date/Time: Tuesday, October 6, 2020 - 3:00 PM – 5:00 PM
Track: Special Interest Group
Log in to Add to My Schedule


Neuromuscular diseases are disabling disorders that can manifest with a spectrum of clinical features and severity at any time, from prenatal life to advanced adulthood.  Immune-mediated, genetic and toxic factors are the most common culprits. The understanding of pathomechanisms underlying each disease plays a crucial role in providing proper patient care and developing novel therapeutic strategies. This session will cover the most recent developments in the field of neuromuscular disorders with special focus on muscle disorders and defects of neuromuscular transmission.


  • To learn about available biomarkers of autoimmune neuromuscular diseases and related clinical and scientific value and specificity.

  • To learn the spectrum of immune checkpoint inhibitors related neuromuscular manifestations.

  • To convey the latest cutting edge advancement on the understanding of congenital myopathies.


Characterizing the Histological and Behavioral Phenotypes of a Humanized Knock-In Mouse Modeling a Deep Intronic Mutation in Collagen VI-Related Dystrophy

Congenital Myopathies: New Advances in Therapy Development

DNAJB6 Isoform Switching: Mechanistic Insights and Therapeutic Potential for Limb Girdle Muscular Dystrophy 1D

Immunologic Biomarkers in Autoimmune Neuromuscular Disease

Machine Learning Optimized Dynamic Meta-analysis to Assess and Predict the Multifactorial Nature of Amyotrophic Lateral Sclerosis

Neuromuscular Immune Related Adverse Events of Immune Checkpoint Inhibitor Therapies: Towards Risk Mitigation and Targeted Therapies